Absorption |
Blood-Brain Barrier | BBB+ | 0.9592 |
Human Intestinal Absorption | HIA+ | 0.9775 |
Caco-2 Permeability | Caco2+ | 0.5356 |
P-glycoprotein Substrate | Non-substrate | 0.9033 |
P-glycoprotein Inhibitor | Non-inhibitor | 0.9565 |
Non-inhibitor | 0.9910 |
Renal Organic Cation Transporter | Non-inhibitor | 0.9224 |
Distribution |
Subcellular localization | Mitochondria | 0.5816 |
Metabolism |
CYP450 2C9 Substrate | Non-substrate | 0.8679 |
CYP450 2D6 Substrate | Non-substrate | 0.8723 |
CYP450 3A4 Substrate | Non-substrate | 0.7124 |
CYP450 1A2 Inhibitor | Non-inhibitor | 0.6971 |
CYP450 2C9 Inhibitor | Non-inhibitor | 0.9230 |
CYP450 2D6 Inhibitor | Non-inhibitor | 0.8861 |
CYP450 2C19 Inhibitor | Non-inhibitor | 0.8439 |
CYP450 3A4 Inhibitor | Non-inhibitor | 0.9830 |
CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.9225 |
Excretion |
Toxicity |
Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.7520 |
Non-inhibitor | 0.9688 |
AMES Toxicity | AMES toxic | 0.5861 |
Carcinogens | Carcinogens | 0.7376 |
Fish Toxicity | Low FHMT | 0.9126 |
Tetrahymena Pyriformis Toxicity | Low TPT | 0.6610 |
Honey Bee Toxicity | High HBT | 0.7523 |
Biodegradation | Ready biodegradable | 0.9864 |
Acute Oral Toxicity | II | 0.6511 |
Carcinogenicity (Three-class) | Non-required | 0.4885 |